亚洲有无码av在线播放,亚洲AV综合一区二区在线观看,亚洲日韩久久综合中文字幕,卡一卡二卡三精品免费,无人一区二区区别是什么

#ArfA#

5篇內(nèi)容 | 693人圍觀

關(guān)注話題

話題活躍用戶

#插入話題

插入圖片

最新最熱

[GetTopicListResponse(id=1780014, encodeId=325a1e80014b3, content=<a href='/topic/show?id=71062e3964' target=_blank style='color:#2F92EE;'>#ArfA#</a>, objectTitle=Espero BioPharma宣布Tecarfarin治療終末期腎病和心房顫動患者獲得FDA孤兒藥物指定, objectType=article, longId=162178, objectId=41161621e864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41161621e864, replyNumber=0, likeNumber=75, createdTime=2019-08-10, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41161621e864, moduleTitle=Espero BioPharma宣布Tecarfarin治療終末期腎病和心房顫動患者獲得FDA孤兒藥物指定, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=41161621e864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780012, encodeId=af131e8001260, content=<a href='/topic/show?id=71062e3964' target=_blank style='color:#2F92EE;'>#ArfA#</a>, objectTitle=PLoS One：Marfan綜合征的生物特征和結(jié)構(gòu)性眼部表型！, objectType=article, longId=113708, objectId=d923113e08b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d923113e08b8, replyNumber=0, likeNumber=61, createdTime=2017-12-16, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d923113e08b8, moduleTitle=PLoS One：Marfan綜合征的生物特征和結(jié)構(gòu)性眼部表型！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d923113e08b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780013, encodeId=77c61e80013cc, content=<a href='/topic/show?id=71062e3964' target=_blank style='color:#2F92EE;'>#ArfA#</a>, objectTitle=JAMA Inter Med：挪威科學(xué)家確定Warfarin阻凝劑預(yù)防癌癥有奇效，有望成為癌癥疫苗, objectType=article, longId=119099, objectId=f5e81190998d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5e81190998d, replyNumber=0, likeNumber=57, createdTime=2017-12-07, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5e81190998d, moduleTitle=JAMA Inter Med：挪威科學(xué)家確定Warfarin阻凝劑預(yù)防癌癥有奇效，有望成為癌癥疫苗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f5e81190998d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780011, encodeId=eed51e800118b, content=<a href='/topic/show?id=71062e3964' target=_blank style='color:#2F92EE;'>#ArfA#</a>, objectTitle=Heart：Marfan綜合征患者FBN1基因型與心血管病變嚴(yán)重程度之間有啥關(guān)系？, objectType=article, longId=97854, objectId=85af9e854df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85af9e854df, replyNumber=0, likeNumber=86, createdTime=2018-02-23, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85af9e854df, moduleTitle=Heart：Marfan綜合征患者FBN1基因型與心血管病變嚴(yán)重程度之間有啥關(guān)系？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=85af9e854df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780010, encodeId=a60b1e800107f, content=<a href='/topic/show?id=71062e3964' target=_blank style='color:#2F92EE;'>#ArfA#</a>, objectTitle=醫(yī)學(xué)故事：一圖讀懂馬凡（Marfan）綜合征, objectType=article, longId=88156, objectId=c3de8815623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3de8815623, replyNumber=0, likeNumber=74, createdTime=2017-05-15, rootId=0, userName=neizongke, userId=f7c9348, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3de8815623, moduleTitle=醫(yī)學(xué)故事：一圖讀懂馬凡（Marfan）綜合征, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c3de8815623)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯話題小助手

ArfA

2020-05-29

neizongke (審核中...)

前往app查看評論內(nèi)容

#ArfA#

Espero BioPharma宣布Tecarfarin治療終末期腎病和心房顫動患者獲得FDA孤兒藥物指定

2019-08-10

neizongke (審核中...)

前往app查看評論內(nèi)容

#ArfA#

PLoS One：Marfan綜合征的生物特征和結(jié)構(gòu)性眼部表型！

2017-12-16

neizongke (審核中...)

前往app查看評論內(nèi)容

#ArfA#

JAMA Inter Med：挪威科學(xué)家確定Warfarin阻凝劑預(yù)防癌癥有奇效，有望成為癌癥疫苗

2017-12-07

neizongke (審核中...)

前往app查看評論內(nèi)容

#ArfA#

Heart：Marfan綜合征患者FBN1基因型與心血管病變嚴(yán)重程度之間有啥關(guān)系？

2018-02-23

neizongke (審核中...)

前往app查看評論內(nèi)容

#ArfA#

醫(yī)學(xué)故事：一圖讀懂馬凡（Marfan）綜合征

2017-05-15

科室
- - 訂閱+
  - 更多科室
工具
服務(wù)

<noscript id="jgzbj"><var id="jgzbj"></var></noscript>

<label id="jgzbj"></label>

<tr id="jgzbj"><strike id="jgzbj"><tr id="jgzbj"></tr></strike></tr>